Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Harvard Business School
Johnson and Johnson
Colorcon
Moodys

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Litigation Details for Pharmacyclics LLC v. Alvogen Pine Brook LLC (D. Del. 2019)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Pharmacyclics LLC v. Alvogen Pine Brook LLC (D. Del. 2019)

Docket   Start Trial Date Filed 2019-03-01
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Colm F. Connolly
Jury Demand None Referred To
Parties ALVOGEN PINE BROOK LLC; JANSSEN BIOTECH, INC.; NATCO PHARMA LTD.; PHARMACYCLICS LLC
Patents 10,010,507; 10,106,548; 10,125,140; 10,213,386; 7,514,444; 8,008,309; 8,476,284; 8,497,277; 8,697,711; 8,735,403; 8,754,090; 8,754,091; 8,952,015; 8,957,079; 9,181,257; 9,296,753; 9,655,857; 9,725,455
Attorneys Christopher D. Lynch; Cristina L. Martinez; David M. Hanna; Hannah Lee; Irena Royzman; Jack B. Blumenfeld; Jeremy A. Tigan; Marcus A. Colucci; Melanie K. Sharp; Michelle M. Ovanesian; Michelle Marie Ovanesian
Firms Morris, Nichols, Arsht & Tunnell; Proskauer Rose LLP; Young, Conaway, Stargatt & Taylor LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Pharmacyclics LLC v. Alvogen Pine Brook LLC
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Pharmacyclics LLC v. Alvogen Pine Brook LLC (D. Del. 2019)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 PageID #: 2 Patent”); 9,655,857 (“the ’857 Patent”); 9,725,455 (“the ’455 Patent”); 10,010,507 (“the ’507… United States Patent Nos. 7,514,444 (“the ’444 Patent”); 8,008,309 (“the ’309 Patent”); 8,476,284 (“…(“the ’284 Patent”); 8,497,277 (“the ’277 Patent”); 8,697,711 (“the ’711 Patent”); 8,735,403 (“the ’403…’403 Patent”); 8,754,090 (“the ’090 Patent”); 8,754,091 (“the ’091 Patent”); 8,952,015 (“the ’015 Patent…507 Patent”); 10,106,548 (“the ’548 Patent”); and 10,125,140 (“the ’140 Patent”). External link to document
0000-00-00 15 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,213,386 . (Blumenfeld, Jack… 1 March 2019 1:19-cv-00434 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
0000-00-00 4 Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,008,309 B2 ;7,514,444 B2 ;8,697,711… 1 March 2019 1:19-cv-00434 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Baxter
Harvard Business School
Dow
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.